Streetbeat News

Products Services

AVXL

Anavex and Partex have agreed to enter into a strategic partnership to co-develop a disease-focused Patient App ecosystem, aiming to drive efficiency, effectiveness, and innovation across the value chain with a patient-centric focus.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2023 | 11:37 am

GSK

The FDA has granted Fast Track designation to GSK plc's investigational vaccine for Neisseria gonorrhea, which is currently in an ongoing Phase 2 trial. Gonorrhea is the second most prevalent bacterial sexually transmitted infection worldwide, with an estimated 82 million new cases yearly. There are no approved vaccines for gonorrhea, and antimicrobial resistance to existing treatments is increasing.

Portfolio Pulse from Vandana Singh

June 27, 2023 | 11:35 am

HARP

Harpoon Therapeutics has completed planned patient enrollment in its Phase 1 study of HPN217 for relapsed/refractory multiple myeloma.

Portfolio Pulse from Bill Haddad

June 27, 2023 | 11:35 am

ARWR

Arrowhead Pharmaceuticals has filed for regulatory clearance to initiate a Phase 1 clinical trial of ARO-SOD1, an RNAi-based investigational medicine for treating amyotrophic lateral sclerosis (ALS) caused by SOD1 mutations. ARO-SOD1 is the first therapeutic candidate leveraging Arrowhead's TRiM platform for CNS delivery.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2023 | 11:35 am

HLNE

TIFIN and Hamilton Lane (HLNE) are partnering to launch an AI-powered investment assistant for private markets, aiming to provide personalized investment recommendations and insights.

Portfolio Pulse from Bill Haddad

June 27, 2023 | 11:35 am

SNY

Sanofi's Phase 2b study of amlitelimab for adults with moderate-to-severe atopic dermatitis met its primary endpoint, showing statistically significant improvements in symptoms. This marks the 5th positive outcome for Sanofi's pipeline since 2023. Amlitelimab was well-tolerated, and no new safety issues were detected.

Portfolio Pulse from Vandana Singh

June 27, 2023 | 11:34 am

ENVX

Enovix has received a purchase order to produce battery cells for the US Army. The size of the order has not been disclosed.

Portfolio Pulse from Bill Haddad

June 27, 2023 | 11:33 am

ANVS

Annovis Bio, a clinical stage drug platform company, has announced the creation of a novel crystalline form of buntanetap (ANVS402) and filed a new composition of matter provisional patent with the U.S. Patent and Trademark Office.

Portfolio Pulse from Bill Haddad

June 27, 2023 | 11:32 am

U

Unity (NYSE:U) has launched a dedicated AI marketplace in the Unity Asset Store, featuring curated solutions to accelerate AI-driven game development and gameplay enhancements. The marketplace centralizes AI tools, including Unity Verified Solutions, community-built solutions, and emerging AI technologies.

Portfolio Pulse from Charles Gross

June 27, 2023 | 11:27 am

ACIU

AC Immune's stock is trading higher after the FDA granted fast track designation for its anti-amyloid-beta active immunotherapy, ACI-24.060, for Alzheimer's disease.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2023 | 11:16 am